BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Revenue (TTM)
$8.21M
Q3 Nov 2011
Net Income (TTM)
−$217.04K
Q3 Nov 2011
EPS Diluted (TTM)
−$0.03
Q3 Nov 2011
Gross Margin
—
Q3 Nov 2011
Operating Margin
-2.8%
Q3 Nov 2011
Net Margin
-2.6%
Q3 Nov 2011
Free Cash Flow (TTM)
—
Q3 Nov 2011
Cash
—
Q3 Nov 2011
Total Debt
—
Q3 Nov 2011
Shares Outstanding
18.91M sh
Q3 Nov 2011